サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1405899

臨床試験サプライ・ロジスティクスの市場規模、シェア、動向分析レポート：サービス別、フェーズ別、治療領域別、最終用途別、地域別、セグメント予測、2024年～2030年

Clinical Trial Supply & Logistics Market Size, Share & Trends Analysis Report By Service (Logistics & Distribution, Storage & Retention), By Phase, By Therapeutic Area, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 137 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
臨床試験サプライ・ロジスティクスの市場規模、シェア、動向分析レポート：サービス別、フェーズ別、治療領域別、最終用途別、地域別、セグメント予測、2024年～2030年
出版日: 2023年12月27日
発行: Grand View Research
ページ情報: 英文 137 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

臨床試験サプライ・ロジスティクス市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の臨床試験サプライ・ロジスティクス市場規模は、2024年から2030年にかけて7.6％のCAGRを記録し、2030年までに62億5,000万米ドルに達すると予測されています。

臨床試験サプライ・ロジスティクス市場における先端技術やイノベーションの台頭、厳格な規制の実施、COVID-19パンデミックのような疾病の流行増加による臨床試験需要の高まりが背景にあります。

当初、COVID-19パンデミックは、サプライチェーンの混乱と、ウイルスの蔓延を防ぐための政府による民間航空会社の削減により、市場にマイナスの影響を与えました。しかし、この病気を予防するためのCOVID-19ワクチンに対する需要の高まりにより、市場はすぐに回復し、大きく成長し始めました。例えば、WHOによると、2022年8月2日現在、臨床開発段階にあるワクチンは169種類、前臨床段階にあるワクチンは198種類あります。

臨床試験用品プロバイダーによるサプライチェーンマネジメント・ソフトウェアへの投資は著しいです。臨床試験の複雑化と市場競争激化が、サプライチェーン管理に新技術を採用する要因となっています。業界各社による新技術の採用が増加していることから、在庫管理、サプライチェーンプランニング、補助的なサプライチェーンマネジメントのためのソフトウェアに対するニーズは高まると予想されます。

臨床試験サプライ・ロジスティクス市場レポートハイライト

  • サービス分野では、ロジスティクス＆流通が2023年の市場シェアを25.33%で独占。これはCOVID-19の流行による臨床試験の増加によるものです。
  • フェーズ別では、フェーズIIIが2023年に最大の売上シェアを占めました。
  • 治療領域別では、心血管疾患が予測期間中最速のCAGR 8.0%を占めました。これは、市場に新規性と革新性をもたらすための市場参入企業による投資件数の増加によるものです。
  • アジア太平洋地域は予測期間中に8.1%の最速成長率を記録すると予測されています。これは、採用コストが低いこと、大規模で多様な患者プールを利用できること、臨床試験に望ましい有利な政策によるものです。

目次

第1章 調査手法と範囲

第2章 臨床試験サプライ・ロジスティクス市場：エグゼクティブサマリー

  • 市場スナップショット
  • サービスとフェーズのスナップショット
  • 治療領域と最終用途のスナップショット
  • 競合情勢のスナップショット

第3章 臨床試験サプライ・ロジスティクス市場の変数、動向、および範囲

  • 市場セグメンテーションと範囲
  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
  • 市場促進要因分析
    • サプライチェーンにおける技術の進歩
    • 製薬会社やバイオ医薬品会社による研究開発投資の増加
    • 治験施設の拡大
  • 市場抑制要因分析
    • 物流に関する厳しい規制。
    • 麻薬の偽造
  • 臨床試験サプライ・ロジスティクス市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTLE分析

第4章 臨床試験サプライ・ロジスティクス：サービスの推定・動向分析

  • サービス市場シェア、2023年と2030年
  • セグメントダッシュボード
  • サービス別の世界の臨床試験サプライ・ロジスティクス市場の見通し
  • 以下の市場規模、予測、動向分析、2018年～2030年
    • 物流・流通
    • 保管・保持
    • 包装、ラベル貼り、目隠し
    • 製造業
    • コンパレータの調達
    • その他

第5章 臨床試験サプライ・ロジスティクス：フェーズの推定・動向分析

  • フェーズ市場シェア、2023年および2030年
  • セグメントダッシュボード
  • フェーズ別の世界の臨床試験サプライ・ロジスティクス市場の見通し
  • 以下の市場規模、予測、動向分析、2018年～2030年
    • フェーズI
    • フェーズ II
    • フェーズⅢ
    • フェーズ IV

第6章 臨床試験サプライ・ロジスティクス：治療領域の推定・動向分析

  • 治療領域の市場シェア、2023年と2030年
  • セグメントダッシュボード
  • 治療領域別の世界の臨床試験サプライ・ロジスティクス市場の見通し
  • 以下の市場規模、予測、動向分析、2018年～2030年
    • 腫瘍学
    • 中枢神経系（CNS）障害
    • 心血管疾患
    • 呼吸器疾患
    • その他

第7章 臨床試験サプライ・ロジスティクス：最終用途の推定・動向分析

  • 最終用途市場シェア、2023年および2030年
  • セグメントダッシュボード
  • 最終用途地域別の世界の臨床試験サプライ・ロジスティクス市場の見通し
  • 以下の市場規模、予測、動向分析、2018年～2030年
    • 医薬品
    • 生物学的製剤
    • 医療機器

第8章 地域ビジネス分析

  • 地域市場シェア分析、2023年および2030年
  • 地域市場ダッシュボード
  • 世界の地域市場のスナップショット
  • マーカーのサイズと予測トレンド分析、2018年～2030年：
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • スペイン
    • フランス
    • イタリア
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • 韓国
    • タイ
    • オーストラリア
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 中東・アフリカの臨床試験サプライ・ロジスティクス市場、2018年から2030年
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第9章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 会社/競合の分類
  • ベンダー情勢
    • List Of Key Distributors And Channel Partners
    • Key Customers
    • Key Company Market Share Analysis, 2023
    • Thermo Fisher Scientific（Patheon）
    • Catalent, Inc.
    • Parexel International（MA）Corporation
    • Almac Group
    • Marken
    • Piramal Pharma Solutions
    • UDG HEALTHCARE
    • DHL
    • FedEx
    • Movianto
    • Packaging Coordinators Inc
図表

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America Clinical Trial Supply & Logistics Market, Region, 2018 - 2030 (USD Million)
  • Table 3 North America Clinical Trial Supply & Logistics Market, By Service, 2018 - 2030 (USD Million)
  • Table 4 North America Clinical Trial Supply & Logistics Market, By Phase, 2018 - 2030 (USD Million)
  • Table 5 North America Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 6 North America Clinical Trial Supply & Logistics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 7 U.S. Clinical Trial Supply & Logistics Market, By Service, 2018 - 2030 (USD Million)
  • Table 8 U.S. Clinical Trial Supply & Logistics Market, By Phase, 2018 - 2030 (USD Million)
  • Table 9 U.S. Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 10 U.S. Clinical Trial Supply & Logistics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 11 Canada Clinical Trial Supply & Logistics Market, By Service, 2018 - 2030 (USD Million)
  • Table 12 Canada Clinical Trial Supply & Logistics Market, By Phase, 2018 - 2030 (USD Million)
  • Table 13 Canada Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 14 Canada Clinical Trial Supply & Logistics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 15 Europe Clinical Trial Supply & Logistics Market, Region, 2018 - 2030 (USD Million)
  • Table 16 Europe Clinical Trial Supply & Logistics Market, By Service, 2018 - 2030 (USD Million)
  • Table 17 Europe Clinical Trial Supply & Logistics Market, By Phase, 2018 - 2030 (USD Million)
  • Table 18 Europe Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 19 Europe Clinical Trial Supply & Logistics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 20 UK Clinical Trial Supply & Logistics Market, By Service, 2018 - 2030 (USD Million)
  • Table 21 UK Clinical Trial Supply & Logistics Market, By Phase, 2018 - 2030 (USD Million)
  • Table 22 UK Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 23 UK Clinical Trial Supply & Logistics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 24 Germany Clinical Trial Supply & Logistics Market, By Service, 2018 - 2030 (USD Million)
  • Table 25 Germany Clinical Trial Supply & Logistics Market, By Phase, 2018 - 2030 (USD Million)
  • Table 26 Germany Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 27 Germany Clinical Trial Supply & Logistics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 28 France Clinical Trial Supply & Logistics Market, By Service, 2018 - 2030 (USD Million)
  • Table 29 France Clinical Trial Supply & Logistics Market, By Phase, 2018 - 2030 (USD Million)
  • Table 30 France Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 31 France Clinical Trial Supply & Logistics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 32 Italy Clinical Trial Supply & Logistics Market, By Service, 2018 - 2030 (USD Million)
  • Table 33 Italy Clinical Trial Supply & Logistics Market, By Phase, 2018 - 2030 (USD Million)
  • Table 34 Italy Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 35 Italy Clinical Trial Supply & Logistics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 36 Spain Clinical Trial Supply & Logistics Market, By Service, 2018 - 2030 (USD Million)
  • Table 37 Spain Clinical Trial Supply & Logistics Market, By Phase, 2018 - 2030 (USD Million)
  • Table 38 Spain Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 39 Spain Clinical Trial Supply & Logistics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 40 Sweden Clinical Trial Supply & Logistics Market, By Service, 2018 - 2030 (USD Million)
  • Table 41 Sweden Clinical Trial Supply & Logistics Market, By Phase, 2018 - 2030 (USD Million)
  • Table 42 Sweden Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 43 Sweden Clinical Trial Supply & Logistics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 44 Norway Clinical Trial Supply & Logistics Market, By Service, 2018 - 2030 (USD Million)
  • Table 45 Norway Clinical Trial Supply & Logistics Market, By Phase, 2018 - 2030 (USD Million)
  • Table 46 Norway Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 47 Norway Clinical Trial Supply & Logistics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 48 Denmark Clinical Trial Supply & Logistics Market, By Service, 2018 - 2030 (USD Million)
  • Table 49 Denmark Clinical Trial Supply & Logistics Market, By Phase, 2018 - 2030 (USD Million)
  • Table 50 Denmark Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 51 Denmark Clinical Trial Supply & Logistics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 52 Asia Pacific Clinical Trial Supply & Logistics Market, Region, 2018 - 2030 (USD Million)
  • Table 53 Asia Pacific Clinical Trial Supply & Logistics Market, By Service, 2018 - 2030 (USD Million)
  • Table 54 Asia Pacific Clinical Trial Supply & Logistics Market, By Phase, 2018 - 2030 (USD Million)
  • Table 55 Asia Pacific Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 56 Asia Pacific Clinical Trial Supply & Logistics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 57 Japan Clinical Trial Supply & Logistics Market, By Service, 2018 - 2030 (USD Million)
  • Table 58 Japan Clinical Trial Supply & Logistics Market, By Phase, 2018 - 2030 (USD Million)
  • Table 59 Japan Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 60 Japan Clinical Trial Supply & Logistics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 61 China Clinical Trial Supply & Logistics Market, By Service, 2018 - 2030 (USD Million)
  • Table 62 China Clinical Trial Supply & Logistics Market, By Phase, 2018 - 2030 (USD Million)
  • Table 63 China Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 64 China Clinical Trial Supply & Logistics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 65 India Clinical Trial Supply & Logistics Market, By Service, 2018 - 2030 (USD Million)
  • Table 66 India Clinical Trial Supply & Logistics Market, By Phase, 2018 - 2030 (USD Million)
  • Table 67 India Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 68 India Clinical Trial Supply & Logistics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 69 Australia Clinical Trial Supply & Logistics Market, By Service, 2018 - 2030 (USD Million)
  • Table 70 Australia Clinical Trial Supply & Logistics Market, By Phase, 2018 - 2030 (USD Million)
  • Table 71 Australia Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 72 Australia Clinical Trial Supply & Logistics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 73 South Korea Clinical Trial Supply & Logistics Market, By Service, 2018 - 2030 (USD Million)
  • Table 74 South Korea Clinical Trial Supply & Logistics Market, By Phase, 2018 - 2030 (USD Million)
  • Table 75 South Korea Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 76 South Korea Clinical Trial Supply & Logistics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 77 Thailand Clinical Trial Supply & Logistics Market, By Service, 2018 - 2030 (USD Million)
  • Table 78 Thailand Clinical Trial Supply & Logistics Market, By Phase, 2018 - 2030 (USD Million)
  • Table 79 Thailand Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 80 Thailand Clinical Trial Supply & Logistics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 81 Latin America Clinical Trial Supply & Logistics Market, Region, 2018 - 2030 (USD Million)
  • Table 82 Latin America Clinical Trial Supply & Logistics Market, By Service, 2018 - 2030 (USD Million)
  • Table 83 Latin America Clinical Trial Supply & Logistics Market, By Phase, 2018 - 2030 (USD Million)
  • Table 84 Latin America Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 85 Latin America Clinical Trial Supply & Logistics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 86 Brazil Clinical Trial Supply & Logistics Market, By Service, 2018 - 2030 (USD Million)
  • Table 87 Brazil Clinical Trial Supply & Logistics Market, By Phase, 2018 - 2030 (USD Million)
  • Table 88 Brazil Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 89 Brazil Clinical Trial Supply & Logistics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 90 Mexico Clinical Trial Supply & Logistics Market, By Service, 2018 - 2030 (USD Million)
  • Table 91 Mexico Clinical Trial Supply & Logistics Market, By Phase, 2018 - 2030 (USD Million)
  • Table 92 Mexico Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 93 Mexico Clinical Trial Supply & Logistics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 94 Argentina Clinical Trial Supply & Logistics Market, By Service, 2018 - 2030 (USD Million)
  • Table 95 Argentina Clinical Trial Supply & Logistics Market, By Phase, 2018 - 2030 (USD Million)
  • Table 96 Argentina Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 97 Argentina Clinical Trial Supply & Logistics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 98 MEA Clinical Trial Supply & Logistics Market, Region, 2018 - 2030 (USD Million)
  • Table 99 MEA Clinical Trial Supply & Logistics Market, By Service, 2018 - 2030 (USD Million)
  • Table 100 MEA Clinical Trial Supply & Logistics Market, By Phase, 2018 - 2030 (USD Million)
  • Table 101 MEA Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 102 MEA Clinical Trial Supply & Logistics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 103 South Africa Clinical Trial Supply & Logistics Market, By Service, 2018 - 2030 (USD Million)
  • Table 104 South Africa Clinical Trial Supply & Logistics Market, By Phase, 2018 - 2030 (USD Million)
  • Table 105 South Africa Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 106 South Africa Clinical Trial Supply & Logistics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 107 Saudi Arabia Clinical Trial Supply & Logistics Market, By Service, 2018 - 2030 (USD Million)
  • Table 108 Saudi Arabia Clinical Trial Supply & Logistics Market, By Phase, 2018 - 2030 (USD Million)
  • Table 109 Saudi Arabia Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 110 Saudi Arabia Clinical Trial Supply & Logistics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 111 UAE Clinical Trial Supply & Logistics Market, By Service, 2018 - 2030 (USD Million)
  • Table 112 UAE Clinical Trial Supply & Logistics Market, By Phase, 2018 - 2030 (USD Million)
  • Table 113 UAE Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 114 UAE Clinical Trial Supply & Logistics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 115 Kuwait Clinical Trial Supply & Logistics Market, By Service, 2018 - 2030 (USD Million)
  • Table 116 Kuwait Clinical Trial Supply & Logistics Market, By Phase, 2018 - 2030 (USD Million)
  • Table 117 Kuwait Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 118 Kuwait Clinical Trial Supply & Logistics Market, By End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Data Triangulation Techniques
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Primary Interviews In North America
  • Fig. 5 Primary Interviews In Europe
  • Fig. 6 Primary Interviews In APAC
  • Fig. 7 Primary Interviews In Latin America
  • Fig. 8 Primary Interviews In MEA
  • Fig. 9 Market Research Approaches
  • Fig. 10 Value-Chain-Based Sizing & Forecasting
  • Fig. 11 QFD Modeling For Market Share Assessment
  • Fig. 12 Market Formulation & Validation
  • Fig. 13 Clinical Trial Supply & Logistics Market: Market Outlook
  • Fig. 14 Clinical Trial Supply & Logistics Competitive Insights
  • Fig. 15 Parent Market Outlook
  • Fig. 16 Related/Ancillary Market Outlook
  • Fig. 17 Penetration And Growth Prospect Mapping
  • Fig. 18 Industry Value Chain Analysis
  • Fig. 19 Clinical Trial Supply & Logistics Market Driver Impact
  • Fig. 20 Clinical Trial Supply & Logistics Market Restraint Impact
  • Fig. 21 Clinical Trial Supply & Logistics Market Strategic Initiatives Analysis
  • Fig. 22 Clinical Trial Supply & Logistics Market: Service Movement Analysis
  • Fig. 23 Clinical Trial Supply & Logistics Market: Service Outlook And Key Takeaways
  • Fig. 24 Logistics & distribution Market Estimates And Forecast, 2018 - 2030
  • Fig. 25 Storage & retention Market Estimates And Forecast, 2018 - 2030
  • Fig. 26 Packaging, labeling, and blinding Market Estimates And Forecast, 2018 - 2030
  • Fig. 27 Manufacturing Market Estimates And Forecast, 2018 - 2030
  • Fig. 28 Comparator sourcing Market Estimates And Forecast, 2018 - 2030
  • Fig. 29 Other Market Estimates And Forecast, 2018 - 2030
  • Fig. 30 Clinical Trial Supply & Logistics Market: Phase Movement Analysis
  • Fig. 31 Clinical Trial Supply & Logistics Market: Phase Outlook And Key Takeaways
  • Fig. 32 Phase I Market Estimates And Forecasts, 2018 - 2030
  • Fig. 33 Phase II Market Estimates And Forecasts, 2018 - 2030
  • Fig. 34 Phase III Market Estimates And Forecasts, 2018 - 2030
  • Fig. 35 Phase IV Market Estimates And Forecasts, 2018 - 2030
  • Fig. 36 Clinical Trial Supply & Logistics Market: Therapeutic Area Movement Analysis
  • Fig. 37 Clinical Trial Supply & Logistics Market: Therapeutic Area Outlook And Key Takeaways
  • Fig. 38 Oncology Market Estimates And Forecasts, 2018 - 2030
  • Fig. 39 Cardiovascular Market Estimates And Forecasts, 2018 - 2030
  • Fig. 40 Respiratory disease Market Estimates And Forecasts, 2018 - 2030
  • Fig. 41 CNS & Mental Disorders Market Estimates And Forecasts, 2018 - 2030
  • Fig. 42 Others Market Estimates And Forecasts, 2018 - 2030
  • Fig. 43 Clinical Trial Supply & Logistics Market: End Use Movement Analysis
  • Fig. 44 Clinical Trial Supply & Logistics Market: End Use Outlook And Key Takeaways
  • Fig. 45 Pharmaceuticals Market Estimates And Forecasts, 2018 - 2030
  • Fig. 46 Biologicals Market Estimates And Forecasts, 2018 - 2030
  • Fig. 47 Medical Device Market Estimates And Forecasts, 2018 - 2030
  • Fig. 48 Global Clinical Trial Supply & Logistics Market: Regional Movement Analysis
  • Fig. 49 Global Clinical Trial Supply & Logistics Market: Regional Outlook And Key Takeaways
  • Fig. 50 Global Clinical Trial Supply & Logistics Market Share And Leading Players
  • Fig. 51 North America Market Share And Leading Players
  • Fig. 52 Europe Market Share And Leading Players
  • Fig. 53 Asia Pacific Market Share And Leading Players
  • Fig. 54 Latin America Market Share And Leading Players
  • Fig. 55 Middle East & Africa Market Share And Leading Players
  • Fig. 56 North America: SWOT
  • Fig. 57 Europe SWOT
  • Fig. 58 Asia Pacific SWOT
  • Fig. 59 Latin America SWOT
  • Fig. 60 MEA SWOT
  • Fig. 61 North America, By Country
  • Fig. 62 North America
  • Fig. 63 North America Market Estimates And Forecasts, 2018 - 2030
  • Fig. 64 U.S.
  • Fig. 65 U.S. Market Estimates And Forecasts, 2018 - 2030
  • Fig. 66 Canada
  • Fig. 67 Canada Market Estimates And Forecasts, 2018 - 2030
  • Fig. 68 Europe
  • Fig. 69 Europe Market Estimates And Forecasts, 2018 - 2030
  • Fig. 70 UK
  • Fig. 71 UK Market Estimates And Forecasts, 2018 - 2030
  • Fig. 72 Germany
  • Fig. 73 Germany Market Estimates And Forecasts, 2018 - 2030
  • Fig. 74 France
  • Fig. 75 France Market Estimates And Forecasts, 2018 - 2030
  • Fig. 76 Italy
  • Fig. 77 Italy Market Estimates And Forecasts, 2018 - 2030
  • Fig. 78 Spain
  • Fig. 79 Spain Market Estimates And Forecasts, 2018 - 2030
  • Fig. 80 Denmark
  • Fig. 81 Denmark Market Estimates And Forecasts, 2018 - 2030
  • Fig. 82 Sweden
  • Fig. 83 Sweden Market Estimates And Forecasts, 2018 - 2030
  • Fig. 84 Norway
  • Fig. 85 Norway Market Estimates And Forecasts, 2018 - 2030
  • Fig. 86 Asia Pacific
  • Fig. 87 Asia Pacific Market Estimates And Forecasts, 2018 - 2030
  • Fig. 88 China
  • Fig. 89 China Market Estimates And Forecasts, 2018 - 2030
  • Fig. 90 Japan
  • Fig. 91 Japan Market Estimates And Forecasts, 2018 - 2030
  • Fig. 92 India
  • Fig. 93 India Market Estimates And Forecasts, 2018 - 2030
  • Fig. 94 Thailand
  • Fig. 95 Thailand Market Estimates And Forecasts, 2018 - 2030
  • Fig. 96 South Korea
  • Fig. 97 South Korea Market Estimates And Forecasts, 2018 - 2030
  • Fig. 98 Australia
  • Fig. 99 Australia Market Estimates And Forecasts, 2018 - 2030
  • Fig. 100 Latin America
  • Fig. 101 Latin America Market Estimates And Forecasts, 2018 - 2030
  • Fig. 102 Brazil
  • Fig. 103 Brazil Market Estimates And Forecasts, 2018 - 2030
  • Fig. 104 Mexico
  • Fig. 105 Mexico Market Estimates And Forecasts, 2018 - 2030
  • Fig. 106 Argentina
  • Fig. 107 Argentina Market Estimates And Forecasts, 2018 - 2030
  • Fig. 108 Middle East And Africa
  • Fig. 109 Middle East And Africa Market Estimates And Forecasts, 2018 - 2030
  • Fig. 110 South Africa
  • Fig. 111 South Africa Market Estimates And Forecasts, 2018 - 2030
  • Fig. 112 Saudi Arabia
  • Fig. 113 Saudi Arabia Market Estimates And Forecasts, 2018 - 2030
  • Fig. 114 UAE
  • Fig. 115 UAE Market Estimates And Forecasts, 2018 - 2030
  • Fig. 116 Kuwait
  • Fig. 117 Kuwait Market Estimates And Forecasts, 2018 - 2030
  • Fig. 118 Market Share Of Key Market Players - Clinical Trial Supply & Logistics Market
目次
Product Code: GVR-4-68038-356-0

Clinical Trials Supply & Logistics Market Growth & Trends:

The global clinical trials supply & logistics market size is expected to reach USD 6.25 billion by 2030, registering a CAGR of 7.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. The rise in advanced technology and innovations in the clinical trial supply & logistics market, implementation of stringent regulations, and the rising demand for clinical trials due to the increasing prevalence of diseases such as the COVID-19 pandemic.

Initially, the COVID-19 pandemic negatively impacted the market due to disruption in the supply chain and a reduction in commercial airlines by the government to prevent the spread of the virus. However, the market soon recovered and started to grow significantly due to rising demand for the COVID-19 vaccine to prevent this disease. For instance, according to WHO, as of August 2, 2022, there are 169 vaccines in the clinical development stage and 198 vaccines in the preclinical phase.

There has been significant investment in supply chain management software by clinical trial supplies providers. Growing complexity in clinical trials and increased competition among market players are factors responsible for the adoption of new technologies in supply chain management. The need for software for inventory management, supply chain planning, and ancillary supply chain management is expected to grow, owing to the increasing adoption of new technologies by industry players.

Clinical Trials Supply & Logistics Market Report Highlights:

  • In service segment, logistics & distribution dominated the market in 2023 with a share of 25.33%. This is due to the rise in clinical trials due to COVID- 19 pandemic
  • Based on phase, The phase III segment accounted for the largest revenue share in 2023
  • Based on therapeutic area, cardiovascular diseases accounted for the fastest CAGR of 8.0% during the forecast period. This is due to the rise in the number of investments by market players for bringing novel and innovation to the market
  • Asia Pacific is anticipated to register the fastest growth rate of 8.1% during the forecast period. This is due to low recruitment cost, region has access to a large and diversified patient pool, and favorable policies that make the region desirable for clinical trials

Table of Contents

Chapter 1. Methodology And Scope

  • 1.1. Market Segmentation And Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Service Segment
      • 1.1.1.2. Phase Segment
      • 1.1.1.3. Therapeutics Area Segment
      • 1.1.1.4. End use segment
  • 1.2. Regional Scope
  • 1.3. Estimates And Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information Or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List Of Primary Sources
  • 1.11. List Of Abbreviations

Chapter 2. Clinical Trial Supply & Logistics Market: Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Services And Phase Snapshots
  • 2.3. Therapeutic Area And End Use Snapshot
  • 2.4. Competitive Landscape Snapshot

Chapter 3. Clinical Trial Supply & Logistics Market Variables, Trends, & Scope

  • 3.1. Market Segmentation And Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers Analysis
    • 3.4.1. Technological advancements in supply chain
    • 3.4.2. Increasing R&D investment by pharmaceutical and biopharmaceutical firms
    • 3.4.3. Expansion of clinical trial sites
  • 3.5. Market Restraint Analysis
    • 3.5.1. Stringent regulation pertaining to logistics.
    • 3.5.2. Counterfeiting of drugs
  • 3.6. Clinical Trial Supply & Logistics Market Analysis Tools
    • 3.6.1. Industry Analysis - Porter's
      • 3.6.1.1. Supplier Power
      • 3.6.1.2. Buyer Power
      • 3.6.1.3. Substitution Threat
      • 3.6.1.4. Threat Of New Entrant
      • 3.6.1.5. Competitive Rivalry
    • 3.6.2. PESTLE Analysis
      • 3.6.2.1. Political Landscape
      • 3.6.2.2. Technological Landscape
      • 3.6.2.3. Economic Landscape

Chapter 4. Clinical Trial Supply & Logistics: Service Estimates & Trend Analysis

  • 4.1. Service Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Clinical Trial Supply & Logistics Market By Service Outlook
  • 4.4. Market Size & Forecasts And Trend Analyses, 2018 To 2030 For The Following
    • 4.4.1. Logistics & Distribution
      • 4.4.1.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 4.4.2. Storage & Retention
      • 4.4.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 4.4.3. Packaging, Labeling, And Blinding
      • 4.4.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 4.4.4. Manufacturing
      • 4.4.4.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 4.4.5. Comparator Sourcing
      • 4.4.5.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 4.4.6. Other
      • 4.4.6.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)

Chapter 5. Clinical Trial Supply & Logistics: Phase Estimates & Trend Analysis

  • 5.1. Phase Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Clinical Trial Supply & Logistics Market By Phase Outlook
  • 5.4. Market Size & Forecasts And Trend Analyses, 2018 To 2030 For The Following
    • 5.4.1. Phase I
      • 5.4.1.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 5.4.2. Phase II
      • 5.4.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 5.4.3. Phase III
      • 5.4.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 5.4.4. Phase IV
      • 5.4.4.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)

Chapter 6. Clinical Trial Supply & Logistics: Therapeutic Area Estimates & Trend Analysis

  • 6.1. Therapeutic Area Market Share, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Global Clinical Trial Supply & Logistics Market By Therapeutic Area Outlook
  • 6.4. Market Size & Forecasts And Trend Analyses, 2018 To 2030 For The Following
    • 6.4.1. Oncology
      • 6.4.1.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.4.2. Central Nervous System (CNS) Disorders
      • 6.4.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.4.3. Cardiovascular Diseases
      • 6.4.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.4.4. Respiratory Diseases
      • 6.4.4.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.4.5. Others
      • 6.4.5.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)

Chapter 7. Clinical Trial Supply & Logistics: End Use Estimates & Trend Analysis

  • 7.1. End use Market Share, 2023 & 2030
  • 7.2. Segment Dashboard
  • 7.3. Global Clinical Trial Supply & Logistics Market By End use Area Outlook
  • 7.4. Market Size & Forecasts And Trend Analyses, 2018 To 2030 For The Following
    • 7.4.1. Pharmaceutical
      • 7.4.1.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 7.4.2. Biologicals
      • 7.4.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 7.4.3. Medical Devices
      • 7.4.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)

Chapter 8. Regional Business Analysis

  • 8.1. Regional Market Share Analysis, 2023 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Global Regional Market Snapshot
  • 8.4. Marker Size, & Forecasts Trend Analysis, 2018 To 2030:
  • 8.5. North America
    • 8.5.1. U.S.
      • 8.5.1.1. Key Country Dynamics
      • 8.5.1.2. Competitive Scenario
      • 8.5.1.3. Regulatory Framework
      • 8.5.1.4. U.S. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.5.2. Canada
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Canada Market Estimates And Forecasts 2018 To 2030 (USD Million)
  • 8.6. Europe
    • 8.6.1. UK
      • 8.6.1.1. Key Country Dynamics
      • 8.6.1.2. Competitive Scenario
      • 8.6.1.3. Regulatory Framework
      • 8.6.1.4. UK Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.6.2. Germany
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Germany Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.6.3. Spain
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Spain Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.6.4. France
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Competitive Scenario
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. France Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.6.5. Italy
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Competitive Scenario
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Italy Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.6.6. Denmark
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Competitive Scenario
      • 8.6.6.3. Regulatory Framework
      • 8.6.6.4. Denmark Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.6.7. Sweden
      • 8.6.7.1. Key Country Dynamics
      • 8.6.7.2. Competitive Scenario
      • 8.6.7.3. Regulatory Framework
      • 8.6.7.4. Sweden Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.6.8. Norway
      • 8.6.8.1. Key Country Dynamics
      • 8.6.8.2. Competitive Scenario
      • 8.6.8.3. Regulatory Framework
      • 8.6.8.4. Norway Market Estimates And Forecasts 2018 To 2030 (USD Million)
  • 8.7. Asia Pacific
    • 8.7.1. JAPAN
      • 8.7.1.1. Key Country Dynamics
      • 8.7.1.2. Competitive Scenario
      • 8.7.1.3. Regulatory Framework
      • 8.7.1.4. Japan Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.7.2. China
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. China Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.7.3. India
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. India Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.7.4. South Korea
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. Competitive Scenario
      • 8.7.4.3. Regulatory Framework
      • 8.7.4.4. South Korea Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.7.5. Thailand
      • 8.7.5.1. Key Country Dynamics
      • 8.7.5.2. Competitive Scenario
      • 8.7.5.3. Regulatory Framework
      • 8.7.5.4. Thailand Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.7.6. Australia
      • 8.7.6.1. Key Country Dynamics
      • 8.7.6.2. Competitive Scenario
      • 8.7.6.3. Regulatory Framework
      • 8.7.6.4. Australia Market Estimates And Forecasts 2018 To 2030 (USD Million)
  • 8.8. Latin America
    • 8.8.1. Brazil
      • 8.8.1.1. Key Country Dynamics
      • 8.8.1.2. Competitive Scenario
      • 8.8.1.3. Regulatory Framework
      • 8.8.1.4. Brazil Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.8.2. Mexico
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. Competitive Scenario
      • 8.8.2.3. Regulatory Framework
      • 8.8.2.4. Mexico Clinical Trial Supply & Logistics Market, 2018 - 2030 (USD Million)
    • 8.8.3. Argentina
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Competitive Scenario
      • 8.8.3.3. Regulatory Framework
      • 8.8.3.4. Argentina Market Estimates And Forecasts 2018 To 2030 (USD Million)
  • 8.9. MEA
    • 8.9.1. MEA Clinical Trial Supply & Logistics Market, 2018 - 2030 (USD Million)
    • 8.9.2. South Africa
      • 8.9.2.1. Key Country Dynamics
      • 8.9.2.2. Competitive Scenario
      • 8.9.2.3. Regulatory Framework
      • 8.9.2.4. South Africa Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.9.3. Saudi Arabia
      • 8.9.3.1. Key Country Dynamics
      • 8.9.3.2. Competitive Scenario
      • 8.9.3.3. Regulatory Framework
      • 8.9.3.4. Saudi Arabia Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.9.4. UAE
      • 8.9.4.1. Key Country Dynamics
      • 8.9.4.2. Competitive Scenario
      • 8.9.4.3. Regulatory Framework
      • 8.9.4.4. UAE Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.9.5. Kuwait
      • 8.9.5.1. Key Country Dynamics
      • 8.9.5.2. Competitive Scenario
      • 8.9.5.3. Regulatory Framework
      • 8.9.5.4. Kuwait Market Estimates And Forecasts 2018 To 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company /Competition Categorization
  • 9.3. Vendor Landscape
    • 9.3.1. List Of Key Distributors And Channel Partners
    • 9.3.2. Key Customers
    • 9.3.3. Key Company Market Share Analysis, 2023
    • 9.3.4. Thermo Fisher Scientific (Patheon)
      • 9.3.4.1. Overview
      • 9.3.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.4.3. Product Benchmarking
      • 9.3.4.4. Strategic Initiatives
    • 9.3.5. Catalent, Inc.
      • 9.3.5.1. Overview
      • 9.3.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.5.3. Product Benchmarking
      • 9.3.5.4. Strategic Initiatives
    • 9.3.6. Parexel International (MA) Corporation
      • 9.3.6.1. Overview
      • 9.3.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.6.3. Product Benchmarking
      • 9.3.6.4. Strategic Initiatives
    • 9.3.7. Almac Group
      • 9.3.7.1. Overview
      • 9.3.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.7.3. Product Benchmarking
      • 9.3.7.4. Strategic Initiatives
    • 9.3.8. Marken
      • 9.3.8.1. Overview
      • 9.3.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.8.3. Product Benchmarking
      • 9.3.8.4. Strategic Initiatives
    • 9.3.9. Piramal Pharma Solutions
      • 9.3.9.1. Overview
      • 9.3.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.9.3. Product Benchmarking
      • 9.3.9.4. Strategic Initiatives
    • 9.3.10. UDG HEALTHCARE
      • 9.3.10.1. Overview
      • 9.3.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.10.3. Product Benchmarking
      • 9.3.10.4. Strategic Initiatives
    • 9.3.11. DHL
      • 9.3.11.1. Overview
      • 9.3.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.11.3. Product Benchmarking
      • 9.3.11.4. Strategic Initiatives
    • 9.3.12. FedEx
      • 9.3.12.1. Overview
      • 9.3.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.12.3. Product Benchmarking
      • 9.3.12.4. Strategic Initiatives
    • 9.3.13. Movianto
      • 9.3.13.1. Overview
      • 9.3.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.13.3. Product Benchmarking
      • 9.3.13.4. Strategic Initiatives
    • 9.3.14. Packaging Coordinators Inc
      • 9.3.14.1. Overview
      • 9.3.14.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.14.3. Product Benchmarking
      • 9.3.14.4. Strategic Initiatives